To the Editor: Acne causes physical disfigurement and is associated with an increased risk for depression and suicidal ideation. 1 Compared with heterosexuals, sexual minorities report higher rates of depression, suicidal ideation, and body image issues. 2, 3 Consequentially, sexual minorities with acne may be a group at high risk for development of mental health problems. This study assesses the impact of sexual orientation on the relationship between acne and mental health.
This cross-sectional study utilized publicly available data from Wave III of the National Longitudinal Study on Adolescent to Adult Health and included 4094 heterosexual and 564 sexual minority U.S. adults aged 18 to 28 years. Acne was defined as use of a prescription acne medication in the last year. Among all study participants (by acne status) and in analyses stratified by acne status (by sexual orientation), we calculated the unadjusted prevalence rates and unadjusted and multivariate-adjusted prevalence odds ratios for all primary outcomes, including any history of depression and recent clinical depression, suicidal ideation, antidepressant use, and psychological counseling. This study was exempt from institutional review board review. Statistical analyses were performed using Stata software (version 13.1, StataCorp, College Station, TX).
Participant characteristics by sexual orientation are presented in Table I . Among all participants, acne was associated with increased odds of reporting a history of depression and suicidal ideation. Both among those with and without acne, compared with heterosexuals, sexual minorities had increased odds of reporting all primary outcomes. The relative increased odds of suicidal ideation for sexual minorities compared with heterosexuals was higher (P interaction ¼ . (Table II) .
This study suggests that acne may be associated with depression and suicidal ideation among young adults. Sexual minorities with acne represent a group at particularly high risk, with more than one-third indicating a history of depression and suicidal ideation. Physical disfigurement likely contributes to depression and social impairment among patients with acne. 1 Elevated baseline rates of depression 2 and the emphasis on body image and appearance 3 among sexual minorities may contribute to these differences.
Study strengths include the use of a nationally representative data set. Limitations include self-reported data, age of data, missing data on type of acne medications (including over-thecounter medications), and reduced statistical power owing to the small number of sexual minorities. Despite the increased odds of reporting a history of depression and recent suicidal ideation, there was no association between acne and current symptoms of clinical depression. This may be explained by increased utilization of psychological care by individuals with acne, particularly sexual minorities, which has been previously shown to improve mood symptoms but not reduce suicidal ideation. 4 Furthermore, treatment of acne improves mood symptoms, but data on treatment length or current acne severity were not available. Dermatologists should be aware of the increased risk for mental health issues among patients with acne, particularly sexual minorities with acne. Validated screening tools to assess sexual orientation 5 and depression 6 among patients with acne may identify at-risk individuals and expedite referral for psychological care. Prospective studies are needed to further explore the relationship between acne, sexual orientation, and mental health. Conflicts of interest: None declared. Dr Mansh had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Gao and Mansh were responsible for drafting the manuscript, and Drs Wei and Mansh were responsible for statistical analysis. All the authors were responsible for the study concept and design; acquisition, analysis, and interpretation of data; critical revision of the manuscript for important intellectual content; and study supervision.
Reprints not available from the authors. To the Editor: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but severe cutaneous hypersensitivity reaction that typically occurs 2 to 8 weeks after continuous exposure to an offending agent (medication). The diagnosis can be challenging and is largely clinical, with manifestations that can include fever, rash, lymphadenopathy, eosinophilia, and internal organ involvement. 1 Current understanding of the pathogenesis, triggers, and predisposing factors for DRESS is incomplete. Several classes of medications have been implicated, including antibiotics, anticonvulsants, and antiretrovirals. 2 The majority of retrospective studies have been published by groups in Asia, and whether these reviews are
